|
| Press Releases |
|
 |
|
| Thursday, February 7, 2019 |
|
|
Sanofi delivers 2018 business EPS growth of 5.1% at CER |
| Sanofi announced the 2018 fourth-quarter and full-year results. more info >> |
|
| Wednesday, February 7, 2018 |
|
|
Sanofi Delivers 2017 Business EPS in line with Guidance |
| Sanofi Delivers 2017 Business EPS in line with Guidance more info >> |
|
| Monday, January 22, 2018 |
|
|
Sanofi to Acquire Bioverativ for $11.6 Billion |
| Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into a definitive agreement under which Sanofi will acquire all of the outstanding shares of Bioverativ for $105 per share in cash, representing an equity value of approximately $11.6 billion (on a fully diluted basis). The transaction was unanimously approved by both the Sanofi and Bioverativ Boards of Directors. more info >> |
|
| Friday, October 6, 2017 |
|
|
Sanofi: Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent(R) (alirocumab) |
| Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Court of Appeals for the Federal Circuit has ordered a new trial and vacated the permanent injunction in the dispute concerning Amgen's asserted patent claims for antibodies targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). This ruling means that Sanofi and Regeneron will continue marketing, selling and manufacturing Praluent(R) (alirocumab) injection in the U.S. more info >> |
|
| Thursday, February 13, 2014 |
|
|
A*STAR, NUS and NUH Join Forces to Understand Immune Erosion in Elderly |
| A*STAR's Singapore Immunology Network (SIgN) signed a three-year partnership with the National University of Singapore (NUS), National University Hospital (NUH) and Sanofi Pasteur to embark on a Phase IV clinical trial to understand age-related loss of immunity, known as immunosenescence, in elderly. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Government of Japan Holds International Forum on Resilience in Collaboration with IAFOR 
Feb 22, 2019 22:00 HKT/SGT
|
|
|
HKTDC unveils plans to drive new business opportunities for Hong Kong
Feb 22, 2019 21:00 HKT/SGT
|
|
|
Asia World Sees Myanmar's New Concrete Road as Catalyst and Confidence Booster for Investments Into Rakhine
Feb 22, 2019 19:00 HKT/SGT
|
|
|
NEC Develops 5G Base Station Equipment Compliant with O-RAN Fronthaul Specifications
Feb 22, 2019 13:55 HKT/SGT
|
|
|
Mobile industry leaders to Develop O-RAN Fronthaul-Compliant Products and Drive Multi-vendor Radio Access Networks
Feb 22, 2019 13:29 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Holds Christening Ceremony for Next-Generation LNG Carrier "MARVEL CRANE"
Feb 22, 2019 12:43 HKT/SGT
|
|
|
Mitsubishi Motors Lineup at 89th Geneva Motor Show
Feb 22, 2019 08:37 HKT/SGT
|
|
|
Champion REIT Announces 2018 Annual Results
Feb 21, 2019 19:27 HKT/SGT
|
|
|
ZEN (SET:ZEN) Undergoes First Trading Day, Confident in Strong Fundamentals
Feb 21, 2019 17:00 HKT/SGT
|
|
|
WARC forecasts global advertising spend to grow 4.3% to $616bn in 2019 but Internet adspend set to decrease 7.2% excluding Google/Facebook duopoly
Feb 21, 2019 16:00 HKT/SGT
|
|
|
AbbVie and Eisai Announce Fully Human Anti-TNF-alpha Monoclonal Antibody HUMIRA is the First in Japan to be Approved for the Treatment of Hidradenitis Suppurativa
Feb 21, 2019 13:50 HKT/SGT
|
|
|
SDK to Begin Shipment of MAMR-Technology-based HD Media
Feb 21, 2019 13:00 HKT/SGT
|
|
|
Hitachi and Hitachi Capital Received an Order for Seawater RO Desalination System
Feb 21, 2019 12:56 HKT/SGT
|
|
|
Lexus to Light Up Milan Design Week with 12th Edition of the Celebrated Lexus Design Event
Feb 21, 2019 11:12 HKT/SGT
|
|
|
NEC Supports the Safety of Automated Driving with Demonstration of Adaptive Network Control Technology
Feb 21, 2019 09:29 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
